A Phase 2 Dose-finding Study of TAK-272 in Participants With Type 2 Diabetes Mellitus and Microalbuminuria

NCT02332824 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

415

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus and Microalbuminuria

Interventions

DRUG: TAK-272
DRUG: TAK-272 Placebo
DRUG: Candesartan cilexetil
DRUG: Candesartan cilexetil Placebo

Sponsor

Takeda